- Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2024 Earnings Results Conference Call
- GENOMMA LAB INTERNACIONAL ANNOUNCES EIGHTH DIVIDEND PAYMENT
- Marzam's New Strategy Will Focus on Strengthening the Company's Position within Pharmaceutical Sector
- Agreement Signed for Share Redemption in Marzam
- Genomma Lab Internacional Announces Results for the First Quarter 2024
- Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
More ▼
Key statistics
On Tuesday, Genomma Lab Internacional SAB de CV (LABB:MEX) closed at 16.57, -11.72% below its 52-week high of 18.77, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.04 |
---|---|
High | 17.22 |
Low | 16.34 |
Bid | -- |
Offer | -- |
Previous close | 17.03 |
Average volume | 3.01m |
---|---|
Shares outstanding | 1.02bn |
Free float | 784.98m |
P/E (TTM) | 14.34 |
Market cap | 16.75bn MXN |
EPS (TTM) | 1.14 MXN |
Annual div (ADY) | 0.3961 MXN |
---|---|
Annual div yield (ADY) | 2.33% |
Div ex-date | Jun 20 2024 |
Div pay-date | Jun 21 2024 |
Data delayed at least 20 minutes, as of Jul 02 2024 20:59 BST.
More ▼